Open Government Canada
Health Product InfoWatch – October 2021
Published by Public Health Agency of Canada | Agence de la santé publique du Canada
About this dataset
Monthly recap of health product safety information. The following is a list of health product advisories, type I recalls and summaries of completed safety reviews published in September 2021 by Health Canada.
Tags
- pandemic
- COVID-19
- Coronavirus
- COVID
- Health
- Product
- InfoWatch
- October
- 2021
- Pharmaceuticals
- biologics
- CellCept
- (mycophenolate mofetil)
- Gadolinium-based
- contrast agents
- Glucagon
- Losartan
- Lumakras (sotorasib)
- Mirvala 28
- Pemazyre (pemigatinib)
- Truseltiq (infigratinib)
- Zepzelca (lurbinectedin)
- Zyloprim (allopurinol)
- Coronavirus disease
- (COVID-19)
- Monthly recap
- New information
- Vaccine
- safety
- biannual
- summary
- January 1
- 2020
- June 30
- Product monograph
- update
- Zyloprim
- (allopurinol)
- Lumakras
- (sotorasib)